SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares MSCI Japan ETF

iShares MSCI Japan ETF

The iShares MSCI Japan ETF (EWJ) is trending amidst significant volatility in Japanese markets, spurred by shifts in Bank of Japan policy signals and the unwinding of the yen carry trade. The community is actively discussing whether record highs and dramatic market swings signify a historic paradigm shift for Japanese equities or an unstable, liquidity-driven environment.

SPDR Series Trust - State Street SPDR S&P Aerospace & Defense ETF

SPDR S&P Aerospace & Defense ETF

The SPDR S&P Aerospace & Defense ETF ($XAR) is trending amidst intensifying global geopolitical tensions and calls for increased defense spending, with the community actively discussing its consistent outperformance as a potential safe haven.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT Inc. is trending as the community speculates on significant defense contracts for its high-energy laser systems, including missile defense initiatives like "Golden Dome," with upcoming showcases at defense shows and recent manufacturing expansion underscoring its pivotal role in modern warfare. Bulls are particularly encouraged by the stock's resilience above a recent private offering price and multiple analyst upgrades, actively countering persistent short-seller sentiment.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

PYTH is trending following a major exchange listing and the introduction of a new token buyback program funded by network revenue, with the community enthusiastically discussing its potential as a leading oracle in the Real-World Assets (RWA) sector.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as investors are actively discussing its significant institutional backing, notably an increased BlackRock stake, and its partnership with NVIDIA for AI-powered air taxis. The community remains divided, however, balancing optimism for upcoming eIPP city selections and potential piloted flights against persistent concerns about delays and an ongoing legal dispute within the eVTOL sector.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending due to its recent pivot from a struggling biotech to an AI-enabled fintech company, CapForce, which is progressing towards a full app launch and Nasdaq relisting. The community is actively discussing the stock's extremely low float and quiet accumulation, speculating on explosive growth potential fueled by increased demand and institutional interest post-relisting.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is a hot topic following its Q3 report, which showed robust revenue growth driven by its e-commerce and fintech segments but missed EPS estimates due to significant investments impacting margins. While many investors remain bullish on its long-term Latin American market leadership and recent analyst upgrades, others express caution about increasing competition, continued margin pressures, and the stock's sensitivity to regional macroeconomic events like Brazil-US tariff discussions and the aftermath of Argentina's election.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is trending as recent Q4 earnings reveal robust Dupixent growth and new drug approvals for Libtayo and Evkeeza, despite ongoing Eylea sales pressure and manufacturing delays for its pre-filled syringe, with the community actively discussing the company's strong pipeline and long-term potential amidst numerous analyst upgrades.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending following positive preliminary financial results and robust early sales of its recently launched fibromyalgia drug, Tonmya, which is attracting significant institutional investment. The community is actively debating the drug's rapid sales trajectory and long-term potential as a non-opioid treatment, questioning if the current market valuation fully reflects its commercial progress and pipeline, despite ongoing discussions about historical dilution.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is trending due to polarized community debate around recent governance shake-ups initiated by CZ-backed YZi Labs and ongoing legal settlements for past compliance issues at Binance. While some accuse Binance of market manipulation and question its integrity, others emphasize BNB's expanding ecosystem, institutional integrations, and resilience as key drivers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Brokerages

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are covering the firm, Marketbeat Ratings reports...

Principal Financial Group Inc. Cuts Holdings in Collegium Pharmaceutical, Inc. $COLL

Principal Financial Group Inc. lowered its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 10.7% during the third quarter, according to its most recent 13F filing with the...

Emerald Mutual Fund Advisers Trust Sells 154,973 Shares of Collegium Pharmaceutical, Inc. $COLL

Emerald Mutual Fund Advisers Trust trimmed its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 28.1% in the third quarter, according to its most recent disclosure...

Collegium Pharmaceutical, Inc. $COLL Shares Sold by Emerald Advisers LLC

Emerald Advisers LLC reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 23.6% during the 3rd quarter, according to the company in its most recent filing with...

Eastern Bank Buys 45,508 Shares of Collegium Pharmaceutical, Inc. $COLL

Eastern Bank lifted its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 487.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities...

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains?

Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.

Why You Should Add Encompass Health to Your Portfolio Now

EHC's expanding rehabilitation hospital network, strong cash flow and growing patient volumes reinforce its market position.

Here's Why You Should Retain Community Health Stock for Now

CYH shows improving occupancy, targeted acquisitions and divestitures and a rising cash flow outlook, making the hospital operator worth holding for now.

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Collegium Pharmaceutical Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

COLL
Collegium Pharmaceutical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest COLL News

COLLCollegium Pharmaceutical Inc